Verastem Inc Price Target Raised By Cantor Fitzgerald
Verastem Inc price target was raised to $17 by Cantor Fitzgerald last week. The new $17 price target represents 330% upside from the previous close of $3.95. Cantor has a
Tag
Therapy
Global Blood Therapeutics Rising Large Players Volume
Global Blood Therapeutics stock has excellent large players volume action. Large players volume is in an uptrend and is confirmed by the rising Twiggs Money Flow.
Global Blood Therapeutics stock has
Sell Immunogen For an Incredible 101% Win
May 7, 2017: Sell Immunogen for a 101% win in 85 days and congratulations if you made money on the trade.
April 19, 2017: Immunogen's stock popped 13% today on
Sell Anavex Life Sciences For a Huge 40% Win
April 30, 2017: Sell Anavex Life Sciences for a huge 40% win and congratulations if you made money on this trade.
January 8, 2017: Institutional traders are accumulating biotechnology firm
Sell Catalyst Pharmaceuticals For a 47% Gain
April 16, 2017: Sell Catalyst Pharmaceuticals for a 47% gain in 60 days and congratulations if you made money on the trade.
January 4, 2017: The popular SeekingAlpha blogger Hawkinvest, with
Sell Global Blood Therapeutics For a Huge 91% Win!
March 4, 2017: Sell Global Blood Therapeutics for a monster 91% win in 41 days! Congratulations if you were able to make money on the trade.
January 4, 2017: JPMorgan
Wells Fargo Gives Buy On Juno One Day, Downgrades the Next!
February 23, 2017: Wells Fargo initiated coverage of JUNO on February 22, 2017 with an Outperform rating. Then, one day later on February 23, 2017, Wells Fargo downgraded JUNO to